Cadmium Patents (Class 424/654)
  • Patent number: 5679378
    Abstract: The invention is directed to Dead Sea mud for restoration of hair growth and retardation of hair loss for those suffering from alopecia and a hair therapy method of topically applying to the scalp of a human or other mammal scalp an effective amount of the Dead Sea mud. Dramatic results in overall hair therapy have been obtained by those individuals that have practiced the present method for a relatively short period of time.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: October 21, 1997
    Assignee: Olim Industries of Israel, North America, Ltd.
    Inventor: Raymond Robert Fischer
  • Patent number: 5618762
    Abstract: An antibacterial ceramic contains an antibacterial material produced by loading an antibacterial metal such as silver on a calcium ceramic carrier and an inorganic material such as cordierite, and has a bulk density of 0.6-1.2 g/cm.sup.3. An antibacterial ceramic filter contains an antibacterial material produced by loading an antibacterial metal such as silver on a calcium ceramic carrier, an aggregate such as mullite, and a binder such as frit, and has a porosity of 20% or more. The light-weight antibacterial ceramic is suitably applicable to a roof garden or the like. The antibacterial ceramic filter can remove and extirpate various bacteria and suspensions.
    Type: Grant
    Filed: May 11, 1995
    Date of Patent: April 8, 1997
    Assignees: NGK Insulators, Ltd., NGK Adrec Co. Ltd., Sangi Co. Ltd.
    Inventors: Hiroshi Shirakawa, Osamu Yamakawa, Hiroaki Nihonmatsu, Kiminori Atsumi
  • Patent number: 5413789
    Abstract: The invention provides a novel antibacterial compound and a process for producing it. Futhermore, the invention provides a novel antibacterial polymer composite comprising a polymer and the antimicrobial compositon.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: May 9, 1995
    Assignees: Hagiwara Research Corp., Japan Electronic Materials Corp.
    Inventors: Zenji Hagiwara, Masao Okubo
  • Patent number: 5358722
    Abstract: Ferritin analogs comprising an apoferritin protein shell and a core substantially devoid of ferrihydrite, e.g. of inorganic composition such as aluminum hydroxide or organic composition such as acetaminophen. The protein shell can be removed from ferritin analog to produce spherules having a substantially monomodal nominal diameter between about 45 and 90 Angstroms.
    Type: Grant
    Filed: January 25, 1993
    Date of Patent: October 25, 1994
    Assignee: Monsanto Company
    Inventor: Bruce F. Monzyk
  • Patent number: 5244667
    Abstract: The present invention provides a novel antimicrobial composition and a process for preparing the composition which composition is useful as antimicrobial and/or bactericidal material. The antimicrobial composition of the invention comprises silica gel and an antimicrobial coat of aluminosilicate on the surface of the silica gel, said composition having a pore volume of at least 0.3 cm.sup.3 /g and a specific surface area of at least 100 m.sup.2 /g. The aluminosilicate coat consists of either partial or complete substitution of ion-exchangeable metal ion (M) in aluminosilicate solid particles represented by the formulaxM.sub.2/n O.Al.sub.2 O.sub.3.ySiO.sub.2.zH.sub.2 O,wherein x and y represent the numbers of molecules of the metal oxide and silicon dioxide, respectively, M is an ion-exchangeable metal, n is the atomic valence of M, and z is the number of molecules of water.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: September 14, 1993
    Assignees: Hagiwara Research Corp., Japan Electronic Materials Corporation
    Inventors: Zenji Hagiwara, Masao Okubo
  • Patent number: 5102670
    Abstract: The invention relates to a method for treating or preventing ocular swelling and corneal-conjunctival inflammation. This is accomplished by administering to the eye of a subject, either before or after exposure to an ocular swelling stimulus, an amount of a heme oxygenase inducing agent sufficient to increase levels of heme oxygenase in the eye and thereby to reduce or to regulate the amount of 12(R) hydroxyeicosatetraenoic and 12(R) DiHETE acids present. Particularly preferred agents include stannous compounds, such as SnCl.sub.2, other metals, heme derivatives and Vitamin B12. These compounds may be administered in various forms.
    Type: Grant
    Filed: September 14, 1990
    Date of Patent: April 7, 1992
    Inventors: Nader G. Abraham, Michal L. Schwartzman, Michael W. Dunn, Richard D. Levere